Colossal Biosciences has successfully hatched chicken embryos inside 3D-printed artificial eggshells, bypassing biological eggs entirely. The startup grew baby chicks in synthetic shells designed to replicate the conditions of a natural egg, including proper gas exchange, humidity, and temperature regulation. The embryos reached the pipping stage, where they began attempting to break through the shell and hatch.
This work targets a fundamental problem in food production. Conventional egg farming ties chickens to constant reproductive cycles, raising welfare and sustainability concerns. By decoupling chicken breeding from living hens, Colossal aims to produce meat and eggs without maintaining flocks solely for reproduction.
The 3D-printed shells function as bioreactors. They provide the precise environment embryos need to develop without a hen's body. The technology requires careful calibration of oxygen permeability, moisture levels, and temperature gradients. Getting these parameters right determines whether embryos survive to hatch.
The implications stretch beyond novelty. If scaled, artificial incubation could reduce the environmental footprint of poultry farming. It eliminates the need to keep millions of laying hens in confinement systems. The approach also opens possibilities for precision agriculture, where genetic traits could be optimized before hatching.
Colossal Biosciences, founded by Harvard genetics researcher George Church, has built a track record in synthetic biology. The company previously worked on de-extinction projects and cellular agriculture. This egg project fits its broader vision of using biotech to reshape food systems.
The technology remains early stage. Hatching a few chicks in lab conditions differs vastly from commercial production at scale. Colossal must demonstrate consistent success rates, cost competitiveness with conventional eggs, and regulatory approval. Food regulators in the US and EU have not yet established clear pathways for lab-grown poultry products